National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Sodium phenylbutyrate (Pheburane®) is indicated as adjunctive therapy in the chronic management of urea cycle disorders, involving deficiencies of carbamylphosphate synthetase, ornithine transcarbamylase or argininosuccinate synthetase.

Rapid Review 

Commenced Completed Outcome
17/07/2013 06/08/2013 Full Pharmacoeconomic Evaluation Not Recommended